Epidemiology of Prostate and Testicular Cancer

Pauline Filippou; James E. Ferguson III; Matthew E. Nielsen

doi:10.1055/s-0036-1586146

Seminars in Interventional Radiology, Inhaltsverzeichnis

Semin intervent Radiol 2016; 33(03): 182-185
DOI: 10.1055/s-0036-1586146

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Epidemiology of Prostate and Testicular Cancer

Autor*innen

Pauline Filippou

¹Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
James E. Ferguson III

¹Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Matthew E. Nielsen

¹Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Abstract

Prostate and testicular cancers account for a large percentage of cancer morbidity in men in the United States and worldwide due to high prevalence rates that continue to grow. Patterns of incidence and mortality vary greatly in both cancers among men of different age groups, ethnicities, and geographic locations. This article summarizes the incidence, prognosis, and risk factors of both prostate and testicular cancers, globally and in the United States.

Keywords

epidemiology - men's health - prostate cancer - testicular cancer - interventional radiology

Volltext

Referenzen

References
1 Testicular Cancer. The American Cancer Society Website. Available at: http://www.cancer.org/cancer/testicularcancer/detailedguide/testicular-cancer-key-statistics . Accessed February 15, 2016
2 Prostate cancer. GLOBOCAN 2012: International Registry for Research on Cancer Website. Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx . Accessed February 15, 2016
3 Hoffman RM, Meisner AL, Arap W , et al. Trends in United States prostate cancer incidence rates by age and stage, 1995-2012. Cancer Epidemiol Biomarkers Prev 2016; 25 (2) 259-263
4 Zhou CK, Check DP, Lortet-Tieulent J , et al. Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group. Int J Cancer 2016; 138 (6) 1388-1400
5 Cancer Statistics Factsheets SEER. Prostate Cancer. National Cancer Institute Web site. Available at: http://seer.cancer.gov/statfacts/html/prost.html . Accessed February 15, 2016
6 Roetzheim RG, Pal N, Tennant C , et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 1999; 91 (16) 1409-1415
7 Grossfeld GD, Latini DM, Downs T, Lubeck DP, Mehta SS, Carroll PR. Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?. J Urol 2002; 168 (6) 2510-2515
8 Howard G, Anderson RT, Russell G, Howard VJ, Burke GL. Race, socioeconomic status, and cause-specific mortality. Ann Epidemiol 2000; 10 (4) 214-223
9 Evans S, Metcalfe C, Ibrahim F, Persad R, Ben-Shlomo Y. Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis. Int J Cancer 2008; 123 (2) 430-435
10 Gaston KE, Kim D, Singh S, Ford III OH, Mohler JL. Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer. J Urol 2003; 170 (3) 990-993
11 Beilin J, Ball EM, Favaloro JM, Zajac JD. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol 2000; 25 (1) 85-96
12 Verhage BA, Aben KK, Witjes JA, Straatman H, Schalken JA, Kiemeney LA. Site-specific familial aggregation of prostate cancer. Int J Cancer 2004; 109 (4) 611-617
13 Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992; 89 (8) 3367-3371
14 Schaid DJ, McDonnell SK, Blute ML, Thibodeau SN. Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet 1998; 62 (6) 1425-1438
15 Cancer Statistics Factsheets SEER. Testicular Cancer. National Cancer Institute Web site. Available at: http://seer.cancer.gov/statfacts/html/testis.html . Accessed February 15, 2016
16 Stevenson SM, Lowrance WT. Epidemiology and diagnosis of testis cancer. Urol Clin North Am 2015; 42 (3) 269-275
17 Le Cornet C, Lortet-Tieulent J, Forman D , et al. Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data. Eur J Cancer 2014; 50 (4) 831-839
18 Rosen A, Jayram G, Drazer M, Eggener SE. Global trends in testicular cancer incidence and mortality. Eur Urol 2011; 60 (2) 374-379
19 Fosså SD, Chen J, Schonfeld SJ , et al. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men. J Natl Cancer Inst 2005; 97 (14) 1056-1066
20 McGlynn KA, Trabert B. Adolescent and adult risk factors for testicular cancer. Nat Rev Urol 2012; 9 (6) 339-349